Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Motivation comes from visible progress and achievable targets; pair goals with simple updates to keep tracking steady.
18,503 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Rising U.S. rents spur interest in a dividend portfolio that pays rent-like income. Analysts compare yields from REIT...
Airline equities tumbled in a broad market selloff after West Texas Intermediate crude surged, lifting fuel costs and...
The Senate faces a stalled path for the Digital Asset Market Clarity Act as Democrats push a stiff ethics provision, ...
Circle’s 2025 results highlight a costly reality: rapid USDC growth came with big distribution costs, uneven margins,...
Roth IRAs are popular for tax-free growth, but they’re not the perfect fit for everyone. Here are three practical rea...
Blue (OBDC) 2025 earnings could signal how well the firm leverages private credit trends and cost discipline. This gu...
A moment on a grand stage can ripple into personal finances. This piece uses the michael jordan delroy lindo event as...
Argentina presses ahead with sweeping reforms, betting on privatizations and tighter budgets. Investors are turning t...
Retirement planning isn’t only about investments. Health coverage decisions during the March window can affect your c...
A DTCC update effective March 2, 2026 unlocks post-trade routing of institutional volumes to the XRP Ledger, as Rippl...
Viemed's 2025 earnings outlook hinges on growing demand for home respiratory care, reimbursement dynamics, and cost c...